drugset / Trial / NCT01984931
Study of Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)for Treatment of Post Operative Nausea and Vomiting
RandomizedParallel-groupDouble-blindPrevention
Summary
This study will determine if giving Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)orally will be effective as a prophylactic anti-emetic drug for patients who underwent arthroscopic rotator cuff repair under general anesthesia.
Timeline
- Start
- 2013-10
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metoclopramide | Small molecule | 8.46 mg | Intravenous |
| Subject | Trimebutine | Small molecule | 300 mg | Oral |
Indications
No indication recorded.